Form 4: KORU Medical Systems Chairman Increases Stake Through Share Acquisition

KORU Medical Systems' Chairman of the Board, R. John Fletcher, acquired 6,284 shares of common stock at $3.58 per share, increasing his total beneficial ownership to 211,846 shares.

Summary

• R. John Fletcher, Chairman of the Board and a Director of KORU Medical Systems, Inc. (KRMD), acquired 6,284 shares of common stock.
• The transaction occurred on July 2, 2025, with shares purchased at a price of $3.58 per share.
• Following this acquisition, R. John Fletcher's total beneficial ownership of KORU Medical Systems common stock stands at 211,846 shares.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase of equity securities, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: The acquisition of shares by a key insider, particularly the Chairman, generally indicates confidence in the company's future, which is a positive signal for investors. The transaction being under a 10b5-1 plan suggests a pre-determined investment strategy.

Positives

• The acquisition of additional shares by the Chairman of the Board, R. John Fletcher, signals continued confidence in the company's future prospects from a key insider.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-planned commitment to increase ownership.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This specific insider transaction reflects an individual's investment decision within the medical systems industry, rather than a broader industry trend or competitive development.

Related Party Transactions

• R. John Fletcher, a Director and Chairman of the Board, acquired 6,284 shares of KORU Medical Systems common stock at $3.58 per share.

Stakeholder Impact

• Shareholders may view the Chairman's increased stake as a positive indicator of management's belief in the company's value and future performance.

Key Dates

Keywords

KORU Medical Systems, KRMD, insider trading, stock acquisition, Form 4, R. John Fletcher, Chairman of the Board, Director, Rule 10b5-1(c)